Five reasons why Bayer boss Anderson is pulling the emergency brake: An overview from a financial perspective

Five reasons why Bayer boss Anderson is pulling the emergency brake: An overview from a financial perspective

According to a report by www.n-tv.de,

Things are getting uncomfortable for the 20,000 or so Bayer employees in this country. Business is going badly and billions in debt are pressing. Bayer boss Bill Anderson now wants to use his might to prepare the company for success. An overview of the construction sites in the DAX group.

The pharmaceutical company Bayer is facing major challenges. The company is planning a strict savings program that is expected to entail “drastic measures” for employees. The group has around 100,000 employees worldwide.

1. Aufgeblähter Verwaltungsapparat: Bayer-Chef Bill Anderson plant eine neue, schlankere Organisationsstruktur, um die Arbeitsabläufe effizienter zu gestalten. Dies könnte zu Stellenabbau führen, während die finanziellen Einsparungen noch offen sind.

2. Difficulties in the pharmaceutical and agricultural sectors: The pharmaceutical sector is suffering from the expiry of patents and the loss of revenue generators. The agricultural business is suffering from high debts and lost sales.

3. Expensive lawsuits resulting from the takeover of Monsanto: The legal costs surrounding the alleged cancer risks of glyphosate products cost the company billions.

4. High debt and negative cash flow: Bayer has high debt and negative cash flow.

5. Fatal price development: Bayer's share price has fallen by 42 percent in the last twelve months. Investors are calling for the company to be split up.

The new measures could lead to an uncertain future for the company and increase pressure on the market. Stock prices could fall further and investors could become increasingly impatient. It remains to be seen how the planned cost-cutting measures and Bayer's realignment will affect the financial industry in the long term.